Biosynex SA signed an agreement to acquire 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors.

Biosynex SA (ENXTPA:ALBIO) signed an agreement to acquire 57.33% interest in ProciseDx Inc. from Nestlé HealthCare Nutrition, Inc., other shareholders, employees, former employees and investors on June 12, 2023. As for consideration, Biosynex SA will pay an initial payment, a deferred payment due on December 28, 2023 and a price supplement which will be paid subject to obtaining marketing authorizations from the FDA.